Pucks To The Head

This note was originally published at 8am on April 14, 2014 for Hedgeye subscribers.

“When you are stuck down a well, someone is bound to throw a rock on your head.”

-Chinese Proverb


So don’t get stuck down a performance well. Rocks to the head hurt. Technically, I’m on vaca with my family this week. But, since I don’t really see what I do (read and write) as a job, I do more of the reading part while I’m watching my kids cannonball one another at the pool.


The aforementioned quote comes from a fantastic Chinese/British economic #history book titled The Opium War. It was describing how English Naval Officer, Charles Elliott, felt after Lin Zexu dumped 20,000 chests of opium into the sea.


This happened in 1839 and became “one of the most celebrated moments in 19th century Chinese history” (pg 69). But it also gave birth to a major economic phase transition. The British found a new island to anchor their opium vessels. It’s called Hong Kong. Changing their position worked.


Back to the Global Macro Grind


The Russell 2000, Nasdaq, and SP500 were down -3.6%, -3.1%, and -2.6% last week to -4.5%, -4.2%, and -1.8% for 2014 YTD. The current “corrections” for the Russell, Nasdaq, and SP500 are -8.0%, -8.2%, and -4.0%. If you are levered long high-multiple growth, those are rocks to the head.


Thankfully, the feedback from our battle tested long-only customers is that they didn’t do that. Instead, they are long of inflation in inflation terms (Food, TIPs, Gold, etc.) and they are long of US #ConsumerSlowing in slow-growth-yield-chasing terms (Utilities, Bonds, etc.).


Feedback from our most astute macro hedge fund subscribers couldn’t be better. Not only can they be long inflation slowing growth, but they can be short of who is taking the brunt of all this (US consumers) in one of the deepest and most liquid markets in the world (US Equities).


Here’s the US Equity Sector Return Score for the YTD:


  1. US Consumer Discretionary Stocks (XLY) down another -3.7% last week to -6.9% YTD
  2. S&P Utilities Sector ETF (XLU) UP another +0.6% in a down tape last week to +9.8% YTD

In other words, as the social media bubbles crash (single stocks down -30-50% from their early March peaks - and we remain The Bears on names like Twitter (TWTR) and YELP), there have been plenty of places to make money, never mind “hide” from US growth beta.


In the face of the US centric bubble popping, check out last week’s top Global Macro performers:


  1. Gold up another +0.6% to +9.6% YTD
  2. Emerging Market Equities (MSCI Index) +1.3% to +1.3% YTD
  3. Emerging Markets LATAM (MSCI) +2.2% to +2.9% YTD

Emerging what?


Yep, lots of our Global Macro value buyers were simply waiting for the rockstar of all Emerging Market Equity catalysts to re-emerge – a Down Dollar. Last week, the US Dollar Index was down another -1.2% to re-test her YTD lows; in kind, Emerging Market Equities hit YTD highs.


I know, so easy a Mucker can do it.


Back to who gets pulverized by an un-elected US Policy To Inflate (courtesy of the Federal Reserve), don’t forget that there are winners who emerge versus US #ConsumerSlowing losers à the countries who get the purchasing power of their people (stronger currencies) back.


To a Keynesian central planner, all of this sounds so 16th century solar system, I am sure. But  reality is that reality is priced in local currency terms – and YTD, for the US consumer at least, reality bites.


Here’s how some commodities (priced in Burning Bucks) did last week:


  1. Coffee up another +8.8% to +76.8% YTD
  2. Natural Gas up another +4.1% to +12.8% YTD
  3. Oil (WTIC) up +2.6% last week to +5.9 YTD

Sure, if you back all that out – and blame the weather (which last I checked is fantabulous)… there is no inflation.


But there is some serious YTD absolute and relative return performance!


Which, at the end of the day is what we are all after, is it not? Why would you pay 20x revenues for anything when 2 of the biggest Macro Risk Factors that matter to any economy (GROWTH and INFLATION) are going the wrong way?


Remember, it’s not about absolutes. It’s about rate of change, and:


  1. US inflation is accelerating
  2. US growth is slowing

Our competition can blame YTD lows in the 10yr bond yield (2.63% = down -39bps YTD) on anything but the most obvious. They can blame me, the weather – or whatever… but they’re stuck in a proverbial well of YTD macro market scores that disagree.


And unless they want to keep taking pucks to the head from a bunch of hockey players, they better find a new narrative come summer time…


Our immediate-term Global Macro Risk Ranges are now:


UST 10yr Yield 2.60-2.72%

SPX 1786-1832

Nasdaq 3953-4158

VIX 14.52-17.99

USD 79.11-80.01

WTIC Oil 101.73-104.99

Gold 1300-1329


Best of luck out there this week,



Keith R. McCullough
Chief Executive Officer


Pucks To The Head - Chart of the Day


TODAY’S S&P 500 SET-UP – April 28, 2014

As we look at today's setup for the S&P 500, the range is 53 points or 1.42% downside to 1837 and 1.43% upside to 1890.                                         













  • YIELD CURVE: 2.25 from 2.23
  • VIX closed at 14.06 1 day percent change of 5.56%

MACRO DATA POINTS (Bloomberg Estimates):

  • Employment Cost Index revisions released
  • 10am: Pending Home Sales m/m, March, est. 0.7% (prior -0.8%)
  • 10:30am: Dallas Fed Mfg Activity, April, est. 6 (prior 4.9)


    • U.S., Philippines to sign defense pact amid China tensions
    • House, Senate return from 2-wk recess
    • Agriculture Sec. Tom Vilsack speaks at Bloomberg Government breakfast, 8:30am
    • Supreme Court Court releases list of cases it plans to consider, 9:30am; hears arguments in Nautilus patent case; 10am


  • Siemens pitches Alstom asset swap, wins France’s support
  • French President Hollande meeting w/GE CEO today; Siemens CEO and chairman also set to meet Hollande
  • ALSTOM STREETWRAP: GE success “better evil” for Siemens
  • Pfizer confirms proposing $98.7b AstraZeneca deal
  • Mylan’s 2nd offer for Swedish drugmaker Meda rejected
  • Merck said near consumer unit sale for $14b: Reuters
  • Bayer said to weigh sale of plastics unit amid health focus
  • Wall Street swap-trading shift abroad draws CFTC scrutiny
  • Apple-Samsung $2b patent case over Google hits last round
  • Charter said to finalize Comcast deal for subscribers: NYT
  • Hartford to sell Japan operation to Orix in $895m deal
  • Och-Ziff African Oil, mining deals probed by SEC, DOJ: WSJ
  • Pimco to BlackRock protest expansion of too-big-to-fail rules
  • Toyota said to plan to shift U.S. sales operations to Texas
  • Putin’s inner circle targeted as U.S., EU prepare sanctions
  • Goodman Fielder rejects $1.2b takeover offer from Wilmar
  • WR Grace said to weigh bid for PQ; Blackstone, KKR drop out
  • Appeals court to weigh Apple bid to delay e-book damages trial
  • General Electric, Metlife strike $1.8b Malaysia deals
  • American Airlines-US Airways merger settlement wins approval
  • China’s largest Bitcoin exchange halts merchants bank deposits


    • Armstrong World Industries (AWI) 7am, $0.44
    • Capitol Federal Financial (CFFN) 9am, $0.13
    • Charter Communications (CHTR) 8am, $(0.09)
    • CNA Financial (CNA) 6am, $0.83
    • CNO Financial (CNO) 7am, $0.27
    • Corning (GLW) 7am, $0.30
    • Ecolab (ECL) 8:30am, $0.74
    • Franklin Resources (BEN) 8:30am, $0.89
    • Laboratory of America (LH) 6:34am, $1.58
    • Loews (L) 6am, $0.70
    • National Oilwell Varco (NOV) 7am, $1.38 - Preview
    • Old National Bancorp (ONB) 9am, $0.26
    • Precision Drilling (PD CN) 6am, C$0.36 - Preview
    • Roper Industries (ROP) 7am, $1.35
    • Tenneco (TEN) 7am, $0.86


    • American Capital Agency (AGNC) 4:01pm, $0.68
    • Ameriprise Financial (AMP) 4:05pm, $1.88
    • Amkor Technology (AMKR) 4:06pm, $0.03
    • CoreLogic (CLGX) 4:10pm, $0.16
    • Crane (CR) 5:48pm, $1.05
    • General Growth Properties (GGP) 4:01pm, $0.05 - Preview
    • Hartford Financial (HIG) 4:15pm, $0.93
    • HealthSouth (HLS) 4:30pm, $0.49
    • Herbalife (HLF) 4:10pm, $1.29
    • Jacobs Engineering (JEC) 8:28pm, $0.89
    • NetSuite (N) 4:05pm, $0.02
    • Norwegian Cruise Line (NCLH) 4pm, $0.22
    • PartnerRe (PRE) 4:15pm, $2.52
    • Plum Creek Timber (PCL) 4:01pm, $0.15
    • Questcor Pharmaceuticals (QCOR) 4:01pm, $1.61
    • Range Resources (RRC) 5:01pm, $0.51
    • Rock-Tenn (RKT) 5pm, $1.53
    • STMicroelectronics (STM IM) 4:46pm, $(0.03)
    • Suncor Energy (SU CN) 10pm, C$0.96 - Preview


  • Nickel at Highest in Almost 15 Months as Sanctions Threat Looms
  • Brent Rises on Ukraine Risk With WTI After Worst Loss in 3 Weeks
  • Gold Bulls Return in Time for Rally on Haven Demand: Commodities
  • Gold Jewelers in India Betting on Festival Rush to Halt Slowdown
  • Crop Futures Climb as Rainy U.S. Weather May Slow Planting Pace
  • Gold Trades Near 1-Week High on Ukraine Crisis as Dollar Slips
  • Arabica Falls for 2nd Session on Profit Taking; Sugar Also Drops
  • Rebar Falls as Iron Ore Drops Amid Reports of Financing Curbs
  • Chavez Food Utopia Withers as Development Plans Left Unfulfilled
  • Hedge Funds Wager on U.S. Gasoline Gains as Exports Rise: Energy
  • Dairy Prices Seen Declining by Rabobank as Chinese Demand Slows
  • Egypt Shariah Loans Rise on Record Sugar Deal: Islamic Finance
  • China Metals Tied Up in Financing Is Mystery Written By Traders
  • China March Gold Imports Drop as Local Discount Curbs Shipments

























The Hedgeye Macro Team














April 28, 2014

April 28, 2014 - Slide1 


April 28, 2014 - Slide2

April 28, 2014 - Slide3

April 28, 2014 - Slide4

April 28, 2014 - Slide5

April 28, 2014 - Slide6 

April 28, 2014 - Slide7

April 28, 2014 - Slide8 



April 28, 2014 - Slide9

April 28, 2014 - Slide10

April 28, 2014 - Slide11
April 28, 2014 - Slide12

Early Look

daily macro intelligence

Relied upon by big institutional and individual investors across the world, this granular morning newsletter distills the latest and most vital market developments and insures that you are always in the know.

Investing Ideas - Levels

Takeaway: Here are Hedgeye CEO Keith McCullough's refreshed levels for our high-conviction stock ideas.

Investing Ideas - Levels - gogo 

Trade :: Trend :: Tail Process - These are three durations over which we analyze investment ideas and themes. Hedgeye has created a process as a way of characterizing our investment ideas and their risk profiles, to fit the investing strategies and preferences of our subscribers.

  • "Trade" is a duration of 3 weeks or less
  • "Trend" is a duration of 3 months or more
  • "Tail" is a duration of 3 years or less

Anything longer than 3 years is unpredictable.



Takeaway: Current Investing Ideas: DRI, HCA, HOLX, LM, LO, OC, RH, and ZQK

Below are Hedgeye analysts' latest updates on our EIGHT current high-conviction investing ideas. We also feature three research notes from earlier this week which offer valuable insight into the markets and two particular stocks.


*Please note we removed CCL from Investing Ideas this week..


*We will send CEO Keith McCullough's updated levels for each stock in a separate email this weekend.


INVESTING IDEAS NEWSLETTER - Price Volume 04.22.2014 


DRI – Managing Director Howard Penney got the news he was looking for on Tuesday, when Starboard Value LP announced it had secured enough votes to call a special shareholder meeting.  The goal of this meeting is to stop the proposed Red Lobster spinoff which would potentially destroy significant shareholder value.  Darden will have 60 days to call the meeting.


Starboard reportedly received 55.5% of the vote.  Although this may look like a slim margin of victory, it is actually quite overwhelming considering the turnover since the record date, the amount of shares short and the retail component.  Starboard Managing Member, Chief Executive Officer and Chief Investing Officer, Jeffrey C. Smith, was very clear about what he believes needs to happen at Darden.  According to him, Mr. Otis is in a hot seat and deservedly so – just look at the chart below.  Many have remarked that Mr. Otis is losing control of the company; ironically, that just took on a whole new meaning. 


Although we may see some near-term volatility as this situation plays out, we remain bullish on Darden as a long-term investment.




HCA – We had flagged rising surgical case volume as a near term reason to remain positive on HCA Holdings coming out of their Q413 earnings. We had specifically noted the acceleration in US Orthopedic sales and what appeared to be a durable relationship with some of our macro data series.


Fast forward to UHS results on Friday and that looks like the right bet. This week both SYK and ZMH put up some decent numbers in their US franchises, although trends slowed modestly. Meanwhile, UHS in talking about a 6.3% increase in revenue per adjusted admission cited ”strengthening surgical volumes,” and fewer “uninsured patients and more Medicaid and commercial insurance patients.” UHS tells us a lot about HCA ahead of their release next week where we are now more convinced we’ll see some upside to numbers. In the chart below you’ll see the same-store revenue per adjusted admission growth rate for the two companies. Coming into hospital earnings the concerns have been the foul weather of Q114 and the Affordable Care Act not delivering much upside. Our data suggested weather was less of an issue than feared and the Affordable Care Act is not the most important driver. Turns out we were right to focus on surgical volume.




HOLX ­­– We believe Hologic will have a good quarter in their Breast Health segment driven by Digital Breast Tomosynthesis products, when they report earnings.  We’ve developed a proprietary way to track placements month to month and the March quarter looks like their best yet.  There is plenty of noise in their other businesses these days to keep in perspective, however. 


The first was this week’s approval of Roche’s HPV test as a first line screen for cervical cancer.  Traditionally the Pap test, which HOLX dominates with their ThinPrep test, has been the first line screen which is then followed by an HPV test for confirmation.  In some ways it makes more sense to screen for cervical cancer by looking directly for the virus that causes the disease first and then do the Pap test if the patient tests positive.  The problem however is that HPV infection is really common, particularly among sexually active women, and is usually harmlessly cleared by the body.  The point is that sorting this out will take a very long time.  OB/GYNs are already coping with guideline changes for the recommended interval between negative test result.  ThinPrep volume is already down in the mid teens and becoming less important by the quarter.   We’re following this closely with a monthly survey, so we should see it coming if things get even worse from here, but we doubt that will happen.


Which brings us back to Breast Health and the DBT trend.  After speaking to a number of experts in the field recently we are getting more confident that the reimbursement Medicare will give DBT this Fall will be high enough to drive a rapid adoption of DBT.  In the short run, we are keeping our eye on negative news items such as the Roche HPV approval, but we’re also keeping it in perspective.  We think the story is DBT and we think they’re having a good quarter.  

LM – We have no material update on our recommendation of Legg Mason as a core long for retail investors. We think that the theme of getting exposure to a defensive bond manager is slowly making its way into the asset management stocks as Legg is the only positive performer in the group year to date. LM stock is up 5.5% thus far in 2014 versus the group average of a decline of 4.4%. We estimate that Legg shares are worth over 20% higher than current prices on an intermediate to long term basis as we see earnings results over 10% higher than our Street competitors and also some multiple expansion on this out of favor stock.


LO – Lorillard reported Q1 2014 results on Thursday that were lukewarm, missing Street estimates on the top and bottom lines, however the stock closed up on the day.


Our long-term bullish outlook remains unchanged and built on 1) the strength and profitability of its advantaged menthol portfolio, 2) our belief in the limited menthol regulatory risk over the longer term, and 3) upside growth in its blu e-cigarette business that commands leading share in the U.S.


CEO Murray Kessler recognized that the convergence of numerous headwinds impacted the quarter’s results: for cigarettes lower wholesale inventory levels, severe weather affecting core markets, a tax increase in Puerto Rico and holiday timing (Easter), as well as in e-cigs lower prices of its rechargables kits and pipeline inventory build versus the year ago-quarter.


All that said, LO had impressive price/mix of +5.8% to offset total cigarette volume decline of -2.9% (outperforming the total industry at -4.0%). Total LO retail market share in the quarter rose 30bps to 15.2%, its highest level ever and its first quarter above 15%, and Newport’s share grew 40bps to 13% while LO’s share of the menthol market was flat Y/Y at 40.7%, but improved 80bps sequentially.


While its e-cig blu contributed a $0.02 loss in the quarter and sales fell for a second straight quarter, the company announced a $10-20MM spend over next 6 to 9 months to rebrand its ownership in SKYCIG in the U.K. as blu and continue to support incremental brand building for blu in the U.S. The playing field in the U.K. is decidedly fragmented, yet the second largest e-cig market behind the U.S. We like LO’s strategy to invest early in its e-cig business to become category leaders.


OC – Owens Corning missed consensus estimates on both top and bottom line mostly stemming from poor weather. So is weather a valid excuse? We think so. It is quite hard to install insulation or roofing products in snow and ice. As a result, the segment data can be quite noisy shown in the graph below. More importantly, we saw margin improvement in its two core segments: Insulation and Composites. Margins held steady and/or improved in a challenging environment bodes well for OC. 2Q should see higher volume across OC’s segments as construction activity picks up heading into the summer. FY 2014 guidance remains unchanged, but is now expected on the lower end. It is hard to put too much weight on 1Q results, but OC will need to deliver in 2Q.




RH – Restoration Hardware had a notable personnel event this week, with the appointment of Dr. Leonard Schlesinger to its Board of Directors. Ordinarily we don’t comment on developments on a company’s Board. But this one is notable – especially given the concern that so many people have about the company’s executive ranks since the departure of its former Co-CEO last year. The new Board member is about as well-decorated as a company the size of RH could hope for. He was Vice Chairman/COO of Limited Brands from 1999 through 2007 and is currently a Professor at Harvard Business School. He has served in numerous other roles in both C-Suites and Academia. We like how well-rounded Schlessinger is – especially given some of the questionable Board appointments we see these days. This is very complimentary to the addition of Doug Diemoz last month as Chief Development Officer.


We don’t expect this to wipe away the concerns of all the people that think that Gary Friedman is a risk being the sole person at the top. But we think that will be addressed by one thing alone – the focus of the management team, and the company’s performance over the next year. Both of those should absolutely be there. In the end, by this time next year, we think that ‘management risk’ will be off the table for people considering RH as an investment (and a part of the short case will be taken out to pasture).


ZQK – On Friday VF Corp announced solid 1Q earnings, which we think has several implications for Quiksilver. First off, VFC is the biggest apparel company that most people never heard of. It owns 30 lifestyle brands including Wrangler, Lee, Timberland, Vans and The North Face. While it operates primarily through wholesale channels, it has 1,100 of its own retail stores across concepts throughout the globe.


So what applies to ZQK? 1) Every division at VFC missed expectations except its Outdoor/Action Sports coalition. Furthermore, the strongest brand in the quarter – and now officially the biggest brand in the portfolio – is Vans. That’s a good sign for the action sports space, and most specifically, ZQK’s DC Shoes division. 2) VFC particularly noted that it’s Southern European business is picking up – where ZQK is particularly strong. 3) Most importantly, this beat shows how important Action Sports is to VFC. There is no question in our minds that VFC will continue to be acquisitive in this space, and as it’s $11bn revenue base continues to grow there are not too many brands it can buy that will make a dent in the financial model. One of the few is ZQK. 4) Add that to the comment from Kering (owner of Gucci, Puma, Volcom, Tretorn, Cobra Golf, YSL, Alexander McQueen, etc…) that it is looking to acquire more sports brands, and that puts ZQK right in the sweet spot. It does not hurt that ZQK CEO Andy Mooney gets a $25mm payday if the stock breaks through $9.28.


We continue to believe that the brand will gain traction organically, until it is ultimately taken out in 1-2 years – likely at a low double-digit price. We think it’s a 2-year double.


*   *   *   *   *   *   *


Click on each title below to unlock the institutional content.


1Q14 Earnings Scorecard

Macro analyst Christian Drake says at the midpoint in Q1 2014 earnings, the trends are looking very much the same as those that prevailed in Q4 2013. 



We Remain Bullish on Chipotle (CMG)

Managing Director Howard Penney remains bullish on CMG, as it continues to take share in an ultra-competitive environment. Recent comp & traffic numbers are unheard of.



Debunking Dillard’s (DDS) at $155—We Like the Short Side

Retail Sector Head Brian McGough says DDS at $155 seems ridiculous. The asset play is maybe $50 on a great day. If people value DDS like a retailer again, the stock’s in trouble.



The Economic Data calendar for the week of the 28th of April through the 2nd of May is full of critical releases and events.  Attached below is a snapshot of some (though far from all) of the headline numbers that we will be focused on.




Enter your email address to receive our newsletter of 5 trending market topics. VIEW SAMPLE

By joining our email marketing list you agree to receive marketing emails from Hedgeye. You may unsubscribe at any time by clicking the unsubscribe link in one of the emails.